Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia-Reference-Cited by-同舟云学术

Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia

Published:2009-02 Issue:3 Volume:144 Page:388-394
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Bhatla Deepika,Gerbing Robert B.,Alonzo Todd A.,Conner Heather,Ross Julie A.,Meshinchi Soheil,Zhai Xiaowen,Zamzow Tiffany,Mehta Parinda A.,Geiger Hartmut,Perentesis John,Davies Stella M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07461.x/fullpdf

Reference43 articles.

1. Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells;Bardenheuer;Leukemia,2005

2. Acute leukemia in adults;Beard;Seminars in Hematology,1974

3. Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex;Betts;Journal of Molecular Biology,1994

4. Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults;Bodey;Cancer Chemotherapy Reports,1969

5. Purification of human cytidine deaminase: molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs;Cacciamani;Archives of Biochemistry and Biophysics,1991

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics;European Journal of Haematology;2022-09-16

2. Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers;Cancers;2021-02-25

3. Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group;Clinical Cancer Research;2020-03-02

4. Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens;Journal of Translational Medicine;2018-07-17

5. Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment;Leukemia & Lymphoma;2017-06-02